Publications

Molecular determinants of outcome to gemcitabine, cisplatin, and nab-paclitaxel in patients with advanced biliary tract cancer

Kim D, Sim NS, Woo S, Kim MH, Lee CK, Hong SS, Kim SH, Hwang HK, Kang CM, Lee WJ, Jo JH, Chung T, Hwang S, Kang B, Kim JS, Kwon CI, Kim S, Chon HJ, Kim CG, Park YN, Choi HJ

Clinical and Molecular Hepatology 32(2), 721–736

Genomic profiling identifies somatic mutations predicting thromboembolic risk in patients with solid tumors

Dunbar A, Bolton KL, Devlin SM, Sanchez-Vega F, Gao J, Mones JV, … Park W, …

Blood 137(15), 2103–2113

Clinical implications of circulating tumor DNA tumor mutational burden (ctDNA TMB) in non-small cell lung cancer

Chae YK, Davis AA, Agte S, Pan A, Simon NI, Iams WT, Cruz MR, … Park W, …

The Oncologist 24(6), 820–828